{
    "2020-08-30": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|中报】泰格医药：投资及中国红利拉动增长，全年主业加速增长仍可期",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "投资",
                        "中国红利",
                        "增长",
                        "主业加速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}